In this Pharmaceutical Executive video interview, Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, discusses findings from IQVIA’s Global Trends in R&D 2024 report including the potential benefits and limitations of novel trial designs and decentralized methodologies.
Benefits and Limitations of Strategies Used to Improve Clinical Development Productivity
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
Estimated read time
1 min read
+ There are no comments
Add yours